ロード中...
Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?
In 2010, the genetic testing criteria was changed to allow women diagnosed ≤ 60 years old with triple negative breast cancer (TNBC) to undergo germline testing. In the same year, estrogen receptor (ER) positivity was defined as having ≥1% ER staining cells. While tumors with 1–10% ER staining cells...
保存先:
| 出版年: | Genes (Basel) |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7763582/ https://ncbi.nlm.nih.gov/pubmed/33302456 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/genes11121469 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|